HCID 12881937, compound → 11,12-Dihydro-4-methoxydibenz(b,f)(1,4)oxazepine-8-carboxylate
Reaction equation
[CH:1]([C:3]1[CH:23]=[CH:22][CH:21]=[C:20]([O:24][CH3:25])[C:4]=1[O:5][C:6]1[CH:16]=[CH:15][C:9]([C:10]([O:12][CH2:13][CH3:14])=[O:11])=[CH:8][C:7]=1[N+:17]([O-])=O)=O>O1CCOCC1.C(O)C.[Ni]>[CH3:25][O:24][C:20]1[C:4]2[O:5][C:6]3[CH:16]=[CH:15][C:9]([C:10]([O:12][CH2:13][CH3:14])=[O:11])=[CH:8][C:7]=3[NH:17][CH2:1][C:3]=2[CH:23]=[CH:22][CH:21]=1Participants
5
Reactant 1
Product 1
Reagents, catalysts & solvents 3
Procedure
A solution of ethyl 4-(2-formyl-6-methoxyphenoxy)-3-nitrobenzoate (145 g) in dioxane (1.2 l) and ethanol (150 ml) was hydrogenated over Raney nickel catalyst (60 ml) at room temperature under atmospheric pressure. After a pre-calculated amount of hydrogen was absorbed, the catalyst was removed by filtration and the filtrate was evaporated under reduced pressure. The residue was treated with ethanol (20 ml) to crystallize and then the separated crystals were collected by filtration. Recrystallization from ethanol gave ethyl 10,11-dihydro-4-methoxydibenz[b,f][1,4]oxazepine-8-caboxylate (96 g) as colorless needles. (Yield: 77%, m.p. 121°-122° C.)
Workup
- customAfter a pre-calculated amount of hydrogen was absorbed
- customthe catalyst was removed by filtration
- customthe filtrate was evaporated under reduced pressure
- additionThe residue was treated with ethanol (20 ml)
- customto crystallize
- filtrationthe separated crystals were collected by filtration
- customRecrystallization from ethanol
Sources & evidence
- ORD record
- ord-5b7da9b2a81a4b3c97052baa8800d72c
- Source dataset
- uspto-grants-1981_09
- Patent number
- US04290953
Reaction notes
Loading…